ChemInform Abstract: Mammalian Target of Rapamycin (mTOR) Inhibitors with Therapeutic Potential for Colitis.

ChemInform Abstract: PKI-179 (I): An Ora

ChemInform Abstract: PKI-179 (I): An Orally Efficacious Dual Phosphatidylinositol-3-kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Inhibitor.

✍ Aranapakam M. Venkatesan; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB

ChemInform Abstract: Pyrazolopyrimidines

ChemInform Abstract: Pyrazolopyrimidines as Highly Potent and Selective, ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin (mTOR): Optimization of the 1-Substituent.

✍ Kevin J. Curran; Jeroen C. Verheijen; Joshua Kaplan; David J. Richard; Lourdes T 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 19 KB

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v

Efficacy and safety of sorafenib in comb

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation

✍ Carlos Gomez-Martin; Javier Bustamante; Javier F. Castroagudin; Magdalena Salced 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

There is currently no consensus on the most suitable treatment for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation. This open, multicenter, retrospective, uncontrolled cohort study was designed to evaluate the safety and preliminary efficacy of the combined use of a mamm

Phase 1 and pharmacokinetic study of eve

Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancer

✍ Suresh S. Ramalingam; R. Donald Harvey; Nabil Saba; Taofeek K. Owonikoko; John K 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB 👁 2 views

ChemInform Abstract: Endoxifen is a New

ChemInform Abstract: Endoxifen is a New Potent Inhibitor of PKC: A Potential Therapeutic Agent for Bipolar Disorder.

✍ Shoukath M. Ali; Ateeq Ahmad; Syed Shahabuddin; Moghis U. Ahmad; Saifuddin Sheik 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 21 KB 👁 1 views

ChemInform Abstract: Glycosylphosphatidy

ChemInform Abstract: Glycosylphosphatidylinositols Are Potential Targets for the Development of Novel Inhibitors for Aerolysin-Type of Pore-Forming Bacterial Toxins

✍ Qiuye Wu; Zhongwu Guo 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable v